Prestige News

Total 70
Number Thumbnail Title Author Date Votes Views
30 Prestige Biopharma to Present Preliminary Phase 1/2a Results of Pancreatic Cancer Antibody PBP1510 at AACR 2025
we******** | 2025.04.01 | Votes 0 | Views 1442
we******** 2025.04.01 0 1442
29 Prestige Biopharma Files Patent for Early Pancreatic Cancer Diagnostic Technology
we******** | 2025.01.22 | Votes 0 | Views 996
we******** 2025.01.22 0 996
28 Prestige Biopharma Secures Japanese Patent for Antibody Drug Candidate PBP1710 Targeting Solid Tumors
김** | 2025.01.21 | Votes 0 | Views 1932
김** 2025.01.21 0 1932
27 Prestige Biopharma Group Accelerates Drug Development with New R&D Hub Backed by KRW 200 Billion Investment
we******** | 2024.11.19 | Votes 0 | Views 1522
we******** 2024.11.19 0 1522
26 Prestige Biopharma IDC to Host First International Symposium on Emerging Biopharmaceutical Modalities
김** | 2024.11.15 | Votes 0 | Views 899
김** 2024.11.15 0 899
25 Prestige Biopharma IDC Opens New Innovative Discovery Center in Busan
김** | 2024.11.15 | Votes 0 | Views 1207
김** 2024.11.15 0 1207
24 Prestige Biopharma IDC CEO Sang-Seok Koh Receives Presidential Commendation
we******** | 2024.11.06 | Votes 0 | Views 960
we******** 2024.11.06 0 960
23 Prestige Biopharma IDC and Aptis Sign Collaboration for Next-Generation ADC Cancer Therapy Development
we******** | 2024.09.26 | Votes 0 | Views 979
we******** 2024.09.26 0 979
22 Prestige Biopharma Receives European Commission Approval for Herceptin Biosimilar Tuznue®
we******** | 2024.09.23 | Votes 0 | Views 1745
we******** 2024.09.23 0 1745
21 Prestige Biopharma Group Participates in BIO USA 2024 Exhibition
김** | 2024.06.16 | Votes 0 | Views 2104
김** 2024.06.16 0 2104